이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

3B Blackbio Dx 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Dhirendra Dubey

최고 경영자

₹11.2m

총 보상

CEO 급여 비율	98.5%
CEO 임기	3.8yrs
CEO 소유권	9.0%
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	9.6yrs

최근 관리 업데이트

Recent updates

CEO 보상 분석

Dhirendra Dubey 의 보수는 3B Blackbio Dx 의 수익과 비교하여 어떻게 변경되었나요?
날짜	총 보상	급여	회사 수익
Jun 30 2024	n/a	n/a	₹366m
Mar 31 2024	₹11m	₹11m	₹321m
Dec 31 2023	n/a	n/a	₹317m
Sep 30 2023	n/a	n/a	₹281m
Jun 30 2023	n/a	n/a	₹249m
Mar 31 2023	₹831k	₹720k	₹259m
Dec 31 2022	n/a	n/a	₹263m
Sep 30 2022	n/a	n/a	₹253m
Jun 30 2022	n/a	n/a	₹191m
Mar 31 2022	₹834k	₹720k	₹322m
Dec 31 2021	n/a	n/a	₹443m
Sep 30 2021	n/a	n/a	₹580m
Jun 30 2021	n/a	n/a	₹891m
Mar 31 2021	₹826k	₹720k	₹1b
Dec 31 2020	n/a	n/a	₹965m
Sep 30 2020	n/a	n/a	₹786m
Jun 30 2020	n/a	n/a	₹294m
Mar 31 2020	₹828k	₹720k	₹77m
Dec 31 2019	n/a	n/a	₹62m
Sep 30 2019	n/a	n/a	₹62m
Jun 30 2019	n/a	n/a	₹54m
Mar 31 2019	₹823k	₹720k	₹52m
Dec 31 2018	n/a	n/a	₹45m
Sep 30 2018	n/a	n/a	₹38m
Jun 30 2018	n/a	n/a	₹35m
Mar 31 2018	₹853k	₹720k	₹34m

보상 대 시장: Dhirendra 의 총 보상 ($USD 133.67K )은 Indian 시장( $USD 38.99K ).

보상과 수익: Dhirendra 의 보상은 지난 1년 동안 20% 이상 증가했습니다.

CEO

Dhirendra Dubey (57 yo)

3.8yrs

테뉴어

₹11,224,872

보상

Mr. Dhirendra Kuber Dubey has been Chairman and Managing Director of 3B Blackbio Dx Limited (formerly known as Kilpest India Limited) since December 30, 2020. He also serves as a Whole Time Director of 3B...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Dhirendra Dubey	Chairman & MD	29.3yrs	₹11.22m	9.05% ₹ 1.0b
Nikhil Dubey	CFO & Whole-Time Director	31.2yrs	₹11.10m	4.18% ₹ 472.8m
Shabbar Husain	Non Executive Independent Director	21.6yrs	₹27.50k	0.029% ₹ 3.3m
Mithla Dubey	Non Executive Director	9.6yrs	₹32.50k	12.37% ₹ 1.4b
Abdul Khan	Non Executive Independent Director	7.1yrs	데이터 없음	0.010% ₹ 1.1m
Harihar Thapak	Independent Non-Executive Director	2.1yrs	₹27.50k	데이터 없음
Rajesh Dubey	Non-Executive Independent Director	less than a year	데이터 없음	데이터 없음

9.6yrs

평균 재임 기간

69yo

평균 연령

경험이 풍부한 이사회: 532067 의 이사회는 경험(평균 재직 기간 9.6 년)으로 간주됩니다.

3B Blackbio Dx 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

3B Blackbio Dx Limited Approves Appointment of Rajesh Dubey as an Independent Director

3B Blackbio Dx Limited, Annual General Meeting, Sep 24, 2024

Kilpest India Limited, Annual General Meeting, Sep 22, 2023

High number of new directors

Kilpest India Limited, Annual General Meeting, Sep 22, 2022

Kilpest India Limited, Annual General Meeting, Sep 22, 2022

Recent updates

3B Blackbio Dx Limited Approves Appointment of Rajesh Dubey as an Independent Director

Dividend increased to ₹3.00

3B Blackbio Dx Limited, Annual General Meeting, Sep 24, 2024

First quarter 2025 earnings released: EPS: ₹13.19 (vs ₹9.60 in 1Q 2024)

New major risk - Share price stability

Investor sentiment improves as stock rises 17%

3B Blackbio Dx Limited to Report Q1, 2025 Results on Aug 12, 2024

New minor risk - Share price stability

Investor sentiment improves as stock rises 38%

Full year 2024 earnings released: EPS: ₹37.46 (vs ₹34.62 in FY 2023)

3B Blackbio Dx Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024

3B Blackbio Dx Limited to Report Q4, 2024 Results on May 29, 2024

Investor sentiment improves as stock rises 15%

Third quarter 2024 earnings released: EPS: ₹9.94 (vs ₹10.27 in 3Q 2023)

3B Blackbio Dx Limited to Report Q3, 2024 Results on Feb 09, 2024

Second quarter 2024 earnings released: EPS: ₹8.86 (vs ₹11.07 in 2Q 2023)

Kilpest India Limited to Report Q2, 2023 Results on Nov 10, 2023

New minor risk - Shareholder dilution

Kilpest India Limited Declares Dividend for the Year Ended March 31, 2023

Upcoming dividend of ₹2.50 per share at 0.3% yield

Kilpest India Limited, Annual General Meeting, Sep 22, 2023

Investor sentiment improves as stock rises 15%

First quarter 2024 earnings released: EPS: ₹9.60 (vs ₹6.28 in 1Q 2023)

Kilpest India Limited to Report Q1, 2024 Results on Aug 11, 2023

Kilpest India Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023

Full year 2023 earnings released: EPS: ₹34.55 (vs ₹42.98 in FY 2022)

Investor sentiment improves as stock rises 17%

Third quarter 2023 earnings released: EPS: ₹10.27 (vs ₹8.74 in 3Q 2022)

Kilpest India Limited to Report Q3, 2023 Results on Feb 14, 2023

Second quarter 2023 earnings released: EPS: ₹11.07 (vs ₹6.84 in 2Q 2022)

Kilpest India Limited to Report Q2, 2023 Results on Nov 12, 2022

High number of new directors

Kilpest India Limited Approves Dividend for the Financial Year 2021-22

Upcoming dividend of ₹2.50 per share

Kilpest India Limited, Annual General Meeting, Sep 22, 2022

Kilpest India Limited, Annual General Meeting, Sep 22, 2022

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: ₹6.28 (vs ₹19.89 in 1Q 2022)

Kilpest India Limited to Report Q1, 2023 Results on Aug 10, 2022

Full year 2022 earnings released: EPS: ₹42.89 (vs ₹152 in FY 2021)

Kilpest India Limited Recommends Final Dividend for the Financial Year Ended March 31, 2022

Less than half of directors are independent

Kilpest India Limited to Report Q4, 2022 Results on May 27, 2022

Investor sentiment improved over the past week

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Kilpest India Limited Recommends Special Interim Dividend for the Fiscal Year 2021-22

Upcoming dividend of ₹9.00 per share

Investor sentiment deteriorated over the past week

First quarter 2022 earnings released

Investor sentiment improved over the past week

Full year 2021 earnings released: EPS ₹152 (vs ₹10.26 in FY 2020)

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Investor sentiment improved over the past week

New 90-day low: ₹281

Third quarter 2021 earnings released: EPS ₹26.20 (vs ₹2.31 in 3Q 2020)

Kilpest India Limited to Report Q3, 2021 Results on Feb 05, 2021

Investor sentiment improved over the past week

Kilpest India Limited to Report Q2, 2021 Results on Nov 05, 2020

Kilpest India Limited Restructure Its Operation At 3B Blackbio Biotech India Limited

Kilpest India Limited to Report Q1, 2021 Results on Jul 31, 2020

CEO 보상 분석

CEO

테뉴어

보상

이사회 구성원

평균 재임 기간